Literature DB >> 7694159

Effect of ajmaline on sustained ventricular tachycardia induced by programmed electrical stimulation in conscious dogs after myocardial infarction.

H Todt1, G Krumpl, N Zojer, K Krejcy, G Raberger.   

Abstract

As yet the antiarrhythmic efficacy of ajmaline with regard to suppressing the induction of sustained ventricular tachycardia after myocardial infarction has not been determined. Therefore, programmed electrical stimulation was performed in 8 conscious, chronically instrumented mongrel dogs 8-20 days after a 4-hour occlusion of the left anterior descending coronary artery. At baseline all animals responded with sustained ventricular tachycardia. Thereafter, ajmaline was administered at two consecutive i.v. doses: a bolus of 0.7 mg kg-1 followed by infusion of 2 mg kg-1 h-1 and infusion of 4 mg kg-1 h-1. The induction of sustained ventricular tachycardia was prevented in 2/8 animals by 2 mg kg-1 h-1 ajmaline and in 1/8 animals by 4 mg kg-1 h-1 ajmaline. During sinus rhythm only 4 mg kg-1 h-1 ajmaline significantly increased QRS-duration and intraventricular activation times, but during rapid right ventricular pacing (cycle length = 330 ms) both doses of ajmaline increased QRS duration and intraventricular conduction times. 4 mg kg-1 h-1 ajmaline also increased the cycle length of induced sustained ventricular tachycardia. In 3 animals induction of sustained ventricular tachycardia during infusion of 4 mg kg-1 h-1 ajmaline was achieved by introduction of less extrastimuli than at baseline. Furthermore the coupling intervals of extrastimuli that induced sustained ventricular tachycardia were substantially prolonged by this dose. Inhomogeneity of conduction between left ventricular normal zone and left ventricular infarct zone was significantly increased by 4 mg kg-1 h-1 ajmaline during rapid right ventricular pacing, but not during sinus rhythm.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694159     DOI: 10.1007/bf00169158

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  34 in total

1.  A proarrhythmic response to sodium channel blockade: modulation of the vulnerable period in guinea pig ventricular myocardium.

Authors:  V V Nesterenko; A A Lastra; L V Rosenshtraukh; C F Starmer
Journal:  J Cardiovasc Pharmacol       Date:  1992-05       Impact factor: 3.105

2.  Cardiac instability amplified by use-dependent Na channel blockade.

Authors:  C F Starmer; A R Lancaster; A A Lastra; A O Grant
Journal:  Am J Physiol       Date:  1992-04

3.  Holter monitoring in conscious dogs. Assessment of arrhythmias occurring in the late reperfusion phase after coronary occlusion.

Authors:  G Krumpl; H Todt; S Schunder-Tatzber; G Raberger
Journal:  J Pharmacol Methods       Date:  1989-09

4.  Differential analysis of the frequency-dependent effects of class 1 antiarrhythmic drugs according to periodical ligand binding: implications for antiarrhythmic and proarrhythmic efficacy.

Authors:  J Weirich; H Antoni
Journal:  J Cardiovasc Pharmacol       Date:  1990-06       Impact factor: 3.105

5.  Mechanism of action of antifibrillatory drugs.

Authors:  P Heistracher
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

6.  Antiarrhythmic efficacy of labetalol as assessed by programmed electrical stimulation.

Authors:  G Krumpl; H Todt; K Krejcy; G Raberger
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

7.  Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation.

Authors:  R H Falk
Journal:  Ann Intern Med       Date:  1989-07-15       Impact factor: 25.391

8.  Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart.

Authors:  K P Anderson; R Walker; R L Lux; P R Ershler; R Menlove; M R Williams; R Krall; D Moddrelle
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

9.  Occurrence of exercise-induced and spontaneous wide complex tachycardia during therapy with flecainide for complex ventricular arrhythmias: a probable proarrhythmic effect.

Authors:  M I Anastasiou-Nana; J L Anderson; J R Stewart; B J Crevey; F G Yanowitz; J R Lutz; T A Johnson
Journal:  Am Heart J       Date:  1987-05       Impact factor: 4.749

10.  Relationship between an arrhythmogenic action of lidocaine and its effects on excitation patterns in acutely ischemic porcine myocardium.

Authors:  D L Carson; R Cardinal; P Savard; C Vasseur; S Nattel; C Lambert; R Nadeau
Journal:  J Cardiovasc Pharmacol       Date:  1986 Jan-Feb       Impact factor: 3.105

View more
  2 in total

1.  Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid.

Authors:  J S Isenberg; Y Jia; L Field; L A Ridnour; A Sparatore; P Del Soldato; A L Sowers; G C Yeh; T W Moody; D A Wink; R Ramchandran; D D Roberts
Journal:  Br J Pharmacol       Date:  2007-03-12       Impact factor: 8.739

Review 2.  Expert consensus on acute management of ventricular arrhythmias - VT network Austria.

Authors:  M Martinek; M Manninger; R Schönbauer; D Scherr; C Schukro; H Pürerfellner; A Petzl; B Strohmer; M Derndorfer; E Bisping; M Stühlinger; L Fiedler
Journal:  Int J Cardiol Heart Vasc       Date:  2021-04-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.